TipRanks
Warby Parker (WRBY)
NYSE:WRBY
US Market
WRBY
Warby Parker
RESEARCH TOOLSreports
Want to see WRBY full AI Analyst Report?

Warby Parker (WRBY) Stock Forecast & Price Target

337 Followers
See the Price Targets and Ratings of:

WRBY Analyst Ratings

Moderate Buy
11Ratings
Moderate Buy
8 Buy
3 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Warby
Parker
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

WRBY Stock 12 Month Forecast

Average Price Target

$30.22
▲(18.61% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Warby Parker in the last 3 months. The average price target is $30.22 with a high forecast of $34.00 and a low forecast of $25.00. The average price target represents a 18.61% change from the last price of $25.48.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"17":"$17","26":"$26","35":"$35","21.5":"$21.5","30.5":"$30.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":34,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$34.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":30.22222222222222,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$30.22</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$25.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[17,21.5,26,30.5,35],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,27.49,27.990769230769228,28.49153846153846,28.99230769230769,29.49307692307692,29.993846153846153,30.494615384615383,30.995384615384616,31.496153846153845,31.996923076923075,32.497692307692304,32.99846153846154,33.49923076923077,{"y":34,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,27.49,27.70017094017094,27.91034188034188,28.12051282051282,28.33068376068376,28.540854700854698,28.75102564102564,28.96119658119658,29.17136752136752,29.38153846153846,29.5917094017094,29.80188034188034,30.01205128205128,{"y":30.22222222222222,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,27.49,27.298461538461538,27.106923076923074,26.915384615384614,26.723846153846154,26.53230769230769,26.34076923076923,26.14923076923077,25.95769230769231,25.766153846153845,25.574615384615385,25.383076923076924,25.19153846153846,{"y":25,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":27.13,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.59,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.79,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.79,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.03,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.29,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.41,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.08,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.38,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.37,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.69,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.19,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.49,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$34.00Average Price Target$30.22Lowest Price Target$25.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs Analyst forecast on WRBY
Brooke Roach
Goldman Sachs
Goldman Sachs
$32
Buy
25.59%
Upside
Reiterated
09/15/26
Analyst Reaffirms Buy on Warby Parker, Citing AI-Driven Intelligent Eyewear Launch and Underpenetrated Growth Opportunities
Piper Sandler Analyst forecast on WRBY
Anna Andreeva
Piper Sandler
Piper Sandler
$32
Buy
25.59%
Upside
Reiterated
09/02/26
Analysts Offer Insights on Healthcare Companies: Warby Parker (NYSE: WRBY), Phibro Animal Health (NASDAQ: PAHC) and Tenet Healthcare (NYSE: THC)
BTIG Analyst forecast on WRBY
Janine Stichter
BTIG
BTIG
$34
Buy
33.44%
Upside
Reiterated
08/14/26
Warby Parker (WRBY) Gets a Buy from BTIG
TD Cowen Analyst forecast on WRBY
Oliver Chen
TD Cowen
TD Cowen
$32
Buy
25.59%
Upside
Reiterated
08/13/26
Analysts Offer Insights on Healthcare Companies: Kailera Therapeutics, Inc. (NASDAQ: KLRA), Warby Parker (NYSE: WRBY) and Aprea Therapeutics (NASDAQ: APRE)
Citizens JMP Analyst forecast on WRBY
Andrew Boone
Citizens JMP
Citizens JMP
$30→$29
Buy
13.81%
Upside
Reiterated
08/07/26
Warby Parker price target lowered to $29 from $30 at CitizensWarby Parker price target lowered to $29 from $30 at Citizens
UBS Analyst forecast on WRBY
Mark Carden
UBS
UBS
$27→$28
Hold
9.89%
Upside
Assigned
08/07/26
Analysts Offer Insights on Healthcare Companies: Warby Parker (NYSE: WRBY), Viatris (NASDAQ: VTRS) and Fisher & Paykel Healthcare Corporation Limited (Other OTC: FSPKF)
Bank of America Securities Analyst forecast on WRBY
Robert Ohmes
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
08/07/26
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (NASDAQ: LGND), AMN Healthcare Services (NYSE: AMN) and Warby Parker (NYSE: WRBY)
Telsey Advisory Analyst forecast on WRBY
Dana Telsey
Telsey Advisory
Telsey Advisory
$33
Buy
29.51%
Upside
Reiterated
08/07/26
Telsey Advisory Reaffirms Their Buy Rating on Warby Parker (WRBY)
Roth MKM Analyst forecast on WRBY
Matt Koranda
Roth MKM
Roth MKM
$27
Hold
5.97%
Upside
Reiterated
08/07/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (NYSE: PFE), Exagen (NASDAQ: XGN) and Warby Parker (NYSE: WRBY)
Stifel Nicolaus Analyst forecast on WRBY
Peter McGoldrick
Stifel Nicolaus
Stifel Nicolaus
$25
Hold
-1.88%
Downside
Reiterated
08/07/26
Warby Parker (WRBY) Gets a Hold from Stifel Nicolaus
William Blair Analyst forecast on WRBY
Dylan Carden
William Blair
William Blair
―
Buy
―
Reiterated
08/04/26
Warby Parker: Buy Rating Backed by Conservative Near-Term Guidance and Anticipation of Smart Glasses Growth Catalyst
Citi Analyst forecast on WRBY
Paul Lejuez
Citi
Citi
$18→$24
Hold
-5.81%
Downside
Assigned
03/18/26
Warby Parker price target raised to $24 from $18 at CitiWarby Parker price target raised to $24 from $18 at Citi
Robert W. Baird Analyst forecast on WRBY
Mark Altschwager
Robert W. Baird
Robert W. Baird
$27→$35
Buy
37.36%
Upside
Reiterated
12/17/25
Robert W. Baird Sticks to Its Buy Rating for Warby Parker (WRBY)
Morgan Stanley Analyst forecast on WRBY
Alexandra Straton
Morgan Stanley
Morgan Stanley
$20→$19
Hold
-25.43%
Downside
Reiterated
11/07/25
Warby Parker price target lowered to $19 from $20 at Morgan StanleyWarby Parker price target lowered to $19 from $20 at Morgan Stanley
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs Analyst forecast on WRBY
Brooke Roach
Goldman Sachs
Goldman Sachs
$32
Buy
25.59%
Upside
Reiterated
09/15/26
Analyst Reaffirms Buy on Warby Parker, Citing AI-Driven Intelligent Eyewear Launch and Underpenetrated Growth Opportunities
Piper Sandler Analyst forecast on WRBY
Anna Andreeva
Piper Sandler
Piper Sandler
$32
Buy
25.59%
Upside
Reiterated
09/02/26
Analysts Offer Insights on Healthcare Companies: Warby Parker (NYSE: WRBY), Phibro Animal Health (NASDAQ: PAHC) and Tenet Healthcare (NYSE: THC)
BTIG Analyst forecast on WRBY
Janine Stichter
BTIG
BTIG
$34
Buy
33.44%
Upside
Reiterated
08/14/26
Warby Parker (WRBY) Gets a Buy from BTIG
TD Cowen Analyst forecast on WRBY
Oliver Chen
TD Cowen
TD Cowen
$32
Buy
25.59%
Upside
Reiterated
08/13/26
Analysts Offer Insights on Healthcare Companies: Kailera Therapeutics, Inc. (NASDAQ: KLRA), Warby Parker (NYSE: WRBY) and Aprea Therapeutics (NASDAQ: APRE)
Citizens JMP Analyst forecast on WRBY
Andrew Boone
Citizens JMP
Citizens JMP
$30→$29
Buy
13.81%
Upside
Reiterated
08/07/26
Warby Parker price target lowered to $29 from $30 at CitizensWarby Parker price target lowered to $29 from $30 at Citizens
UBS Analyst forecast on WRBY
Mark Carden
UBS
UBS
$27→$28
Hold
9.89%
Upside
Assigned
08/07/26
Analysts Offer Insights on Healthcare Companies: Warby Parker (NYSE: WRBY), Viatris (NASDAQ: VTRS) and Fisher & Paykel Healthcare Corporation Limited (Other OTC: FSPKF)
Bank of America Securities Analyst forecast on WRBY
Robert Ohmes
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
08/07/26
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (NASDAQ: LGND), AMN Healthcare Services (NYSE: AMN) and Warby Parker (NYSE: WRBY)
Telsey Advisory Analyst forecast on WRBY
Dana Telsey
Telsey Advisory
Telsey Advisory
$33
Buy
29.51%
Upside
Reiterated
08/07/26
Telsey Advisory Reaffirms Their Buy Rating on Warby Parker (WRBY)
Roth MKM Analyst forecast on WRBY
Matt Koranda
Roth MKM
Roth MKM
$27
Hold
5.97%
Upside
Reiterated
08/07/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (NYSE: PFE), Exagen (NASDAQ: XGN) and Warby Parker (NYSE: WRBY)
Stifel Nicolaus Analyst forecast on WRBY
Peter McGoldrick
Stifel Nicolaus
Stifel Nicolaus
$25
Hold
-1.88%
Downside
Reiterated
08/07/26
Warby Parker (WRBY) Gets a Hold from Stifel Nicolaus
William Blair Analyst forecast on WRBY
Dylan Carden
William Blair
William Blair
―
Buy
―
Reiterated
08/04/26
Warby Parker: Buy Rating Backed by Conservative Near-Term Guidance and Anticipation of Smart Glasses Growth Catalyst
Citi Analyst forecast on WRBY
Paul Lejuez
Citi
Citi
$18→$24
Hold
-5.81%
Downside
Assigned
03/18/26
Warby Parker price target raised to $24 from $18 at CitiWarby Parker price target raised to $24 from $18 at Citi
Robert W. Baird Analyst forecast on WRBY
Mark Altschwager
Robert W. Baird
Robert W. Baird
$27→$35
Buy
37.36%
Upside
Reiterated
12/17/25
Robert W. Baird Sticks to Its Buy Rating for Warby Parker (WRBY)
Morgan Stanley Analyst forecast on WRBY
Alexandra Straton
Morgan Stanley
Morgan Stanley
$20→$19
Hold
-25.43%
Downside
Reiterated
11/07/25
Warby Parker price target lowered to $19 from $20 at Morgan StanleyWarby Parker price target lowered to $19 from $20 at Morgan Stanley
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ONCBeOne Medicines
OVIDOvid Therapeutics
ASNDAscendis Pharma
QNCXQuince Therapeutics
EHCEncompass Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Warby Parker

3 Months
Anna AndreevaPiper Sandler
Success Rate
9/13 ratings generated profit
69%
Average Return
+15.35%
Copying Anna Andreeva's trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +15.35% per trade.
1 Year
Janine StichterBTIG
Success Rate
13/15 ratings generated profit
87%
Average Return
+21.51%
Copying Janine Stichter's trades and holding each position for 1 Year would result in 86.67% of your transactions generating a profit, with an average return of +21.51% per trade.
2 Years
Janine StichterBTIG
Success Rate
14/15 ratings generated profit
93%
Average Return
+37.17%
Copying Janine Stichter's trades and holding each position for 2 Years would result in 93.33% of your transactions generating a profit, with an average return of +37.17% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

WRBY Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
13
14
12
12
10
Hold
4
3
3
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
17
17
15
15
13
In the current month, WRBY has received 10 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. WRBY average Analyst price target in the past 3 months is 30.22.
Each month's total comprises the sum of three months' worth of ratings.

WRBY Financial Forecast

WRBY Earnings Forecast

Next quarter’s earnings estimate for WRBY is $0.10 with a range of $0.04 to $0.13. The previous quarter’s EPS was $0.17. WRBY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year WRBY has Performed in-line its overall industry.
Next quarter’s earnings estimate for WRBY is $0.10 with a range of $0.04 to $0.13. The previous quarter’s EPS was $0.17. WRBY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year WRBY has Performed in-line its overall industry.

WRBY Sales Forecast

Next quarter’s sales forecast for WRBY is $245.03M with a range of $243.20M to $246.70M. The previous quarter’s sales results were $235.51M. WRBY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year WRBY has Performed in-line its overall industry.
Next quarter’s sales forecast for WRBY is $245.03M with a range of $243.20M to $246.70M. The previous quarter’s sales results were $235.51M. WRBY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year WRBY has Performed in-line its overall industry.

WRBY Stock Forecast FAQ

What is WRBY’s average 12-month price target, according to analysts?
Based on analyst ratings, Warby Parker’s 12-month average price target is 30.22.
    What is WRBY’s upside potential, based on the analysts’ average price target?
    Warby Parker has 18.61% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is WRBY a Buy, Sell or Hold?
          Warby Parker has a consensus rating of Moderate Buy which is based on 8 buy ratings, 3 hold ratings and 0 sell ratings.
            What is Warby Parker’s price target?
            The average price target for Warby Parker is 30.22. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $34.00 ,the lowest forecast is $25.00. The average price target represents 18.61% Increase from the current price of $25.48.
              What do analysts say about Warby Parker?
              Warby Parker’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of WRBY?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.